NCT03250130View on ClinicalTrials.gov

Hypnosis for Patients Treated With Adjuvant Chemotherapy for Breast Cancer(HYPNOVAL)

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

July 1, 2015

Primary Completion Date

September 1, 2016

Study Completion Date

June 6, 2017

Conditions
Breast Cancer
Interventions
BEHAVIORAL

hypnosis

The patient achieve self-hypnosis sessions in these chemotherapy treatments

Trial Locations (1)

34298

Institut régional du Cancer de montpellier, Montpellier

All Listed Sponsors
lead

Institut du Cancer de Montpellier - Val d'Aurelle

OTHER

NCT03250130 - Hypnosis for Patients Treated With Adjuvant Chemotherapy for Breast Cancer(HYPNOVAL) | Biotech Hunter | Biotech Hunter